Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Measuring participation as defined by the World Health Organization in the International Classification of Functioning, Disability and Health. Psychometric properties of the Ghent Participation Scale.
Mitochondrial DNA Variation and Heteroplasmy in Monozygotic Twins Clinically Discordant for Multiple Sclerosis.
Rare onset symptoms in multiple sclerosis.
The Charcot Lecture | Beating MS: A story of B cells, with twists and turns.
Salvianolic acid B protects the myelin sheath around injured spinal cord axons.
Evaluation of quality of life and fatigue in radiologically isolated syndrome.
Pharmacokinetics and pharmacodynamics of IFN-beta 1a in healthy volunteers.
Prevalence of people who could benefit from augmentative and alternative communication (AAC) in the UK: determining the need.
New data from Phase 3 studies provide additional evidence supporting treatment effect for oral BG-12 (dimethyl fumarate) in multiple sclerosis
Voiding Dysfunction in Multiple Sclerosis.
Is No Evidence of Disease Activity a Realistic Goal for Patients With Multiple Sclerosis?
VLA-4/CD49d downregulated on primed T lymphocytes during interferon-beta therapy in multiple sclerosis.
Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes.
Diagnosis and treatment of hyponatraemia.
Zebrafish: A new vertebrate model for visualizing myelination in vivo.
Treatment Options to Reduce Disease Activity After Natalizumab: Paradoxical Effects of Corticosteroids.
Treating Post-traumatic Stress Disorder in Patients with Multiple Sclerosis: A Randomized Controlled Trial Comparing the Efficacy of Eye Movement Desensitization and Reprocessing and Relaxation Therapy.
Immunopathology: autoimmune glial diseases and differentiation from multiple sclerosis.
Effect of therapeutic horseback riding on balance and gait of people with multiple sclerosis.
The role of pre-morbid intelligence and cognitive reserve in predicting cognitive efficiency in a sample of Italian elderly.
Assessment of cancer risk with β-interferon treatment for multiple sclerosis.
Efficacy of mitoxantrone in neuromyelitis optica spectrum: clinical and neuroradiological study.
Glatiramer Acetate Protects Against Inflammatory Synaptopathy in Experimental Autoimmune Encephalomyelitis.
Potassium channel KIR4.1 as an immune target in multiple sclerosis.
Some recent advances in multiple sclerosis.

Pages